- Home
- CYRX vs NMRA Comparison
CYRX vs NMRA Comparison
Compare CYRX & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- NMRA
- Stock Information
- Founded
- CYRX 1999
- NMRA 2019
- Country
- CYRX United States
- NMRA United States
- Employees
- CYRX N/A
- NMRA N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- NMRA
- Sector
- CYRX Health Care
- NMRA
- Exchange
- CYRX Nasdaq
- NMRA Nasdaq
- Market Cap
- CYRX 310.4M
- NMRA 287.6M
- IPO Year
- CYRX N/A
- NMRA 2023
- Fundamental
- Price
- CYRX $5.55
- NMRA $0.65
- Analyst Decision
- CYRX Strong Buy
- NMRA Buy
- Analyst Count
- CYRX 7
- NMRA 8
- Target Price
- CYRX $11.29
- NMRA $9.29
- AVG Volume (30 Days)
- CYRX 559.3K
- NMRA 1.2M
- Earning Date
- CYRX 05-06-2025
- NMRA 05-06-2025
- Dividend Yield
- CYRX N/A
- NMRA N/A
- EPS Growth
- CYRX N/A
- NMRA N/A
- EPS
- CYRX N/A
- NMRA N/A
- Revenue
- CYRX $228,385,000.00
- NMRA N/A
- Revenue This Year
- CYRX N/A
- NMRA N/A
- Revenue Next Year
- CYRX $5.30
- NMRA N/A
- P/E Ratio
- CYRX N/A
- NMRA N/A
- Revenue Growth
- CYRX N/A
- NMRA N/A
- 52 Week Low
- CYRX $4.58
- NMRA $0.62
- 52 Week High
- CYRX $17.41
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- CYRX 46.04
- NMRA 22.34
- Support Level
- CYRX $5.34
- NMRA $0.64
- Resistance Level
- CYRX $5.97
- NMRA $0.83
- Average True Range (ATR)
- CYRX 0.66
- NMRA 0.09
- MACD
- CYRX 0.02
- NMRA 0.02
- Stochastic Oscillator
- CYRX 38.82
- NMRA 6.68
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.